2024 年部分亚洲国家和澳大利亚的癌症死亡率预测,重点是胃癌。

C. Santucci, S. Mignozzi, F. Levi, M. Malvezzi, P. Bertuccio, A. Odone, M. C. Camargo, C. La Vecchia, Eva Negri
{"title":"2024 年部分亚洲国家和澳大利亚的癌症死亡率预测,重点是胃癌。","authors":"C. Santucci, S. Mignozzi, F. Levi, M. Malvezzi, P. Bertuccio, A. Odone, M. C. Camargo, C. La Vecchia, Eva Negri","doi":"10.1097/CEJ.0000000000000889","DOIUrl":null,"url":null,"abstract":"INTRODUCTION\nWe estimated cancer mortality figures in five major Asian countries and Australia for 2024, focusing on stomach cancer, a leading cause of cancer-related deaths in Eastern Asia.\n\n\nMETHODS\nWe computed country- and sex-specific annual age-standardized rates (ASRs) for total cancers and the 10 most common cancer sites, using WHO and the United Nations Population Division databases from 1970 to 2021 or the latest available year. We predicted figures for 2024 and estimated the number of avoided cancer deaths in 1994-2024.\n\n\nRESULTS\nAll cancers combined ASR declined between 2015-2019 and 2024 across considered countries and sexes. In 2024, the lowest predicted male rate is in the Philippines (75.0/100 000) and the highest in Australia (94.2/100 000). The Republic of Korea is predicted to have the lowest female ASR (42.1/100 000) while the Philippines the highest (74.5/100 000). Over the last three decades, 121 300 deaths were estimated to be avoided in Hong Kong SAR, 69 500 in Israel, 1 246 300 in Japan, 653 300 in the Republic of Korea, 303 300 in Australia, and 89 700 among Philippine men. Mortality from stomach cancer has been decreasing since 1970 in all considered countries and both sexes. Significant decreases are at all age groups Male rates remain, however, high in Japan (8.7/100 000) and the Republic of Korea (6.2/100 000).\n\n\nCONCLUSION\nDeclining cancer mortality is predicted in the considered countries, notably reducing stomach cancer burden. Stomach cancer, however, remains a major public health issue in East Asia.","PeriodicalId":11950,"journal":{"name":"European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cancer mortality predictions for 2024 in selected Asian countries and Australia with focus on stomach cancer.\",\"authors\":\"C. Santucci, S. Mignozzi, F. Levi, M. Malvezzi, P. Bertuccio, A. Odone, M. C. Camargo, C. La Vecchia, Eva Negri\",\"doi\":\"10.1097/CEJ.0000000000000889\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"INTRODUCTION\\nWe estimated cancer mortality figures in five major Asian countries and Australia for 2024, focusing on stomach cancer, a leading cause of cancer-related deaths in Eastern Asia.\\n\\n\\nMETHODS\\nWe computed country- and sex-specific annual age-standardized rates (ASRs) for total cancers and the 10 most common cancer sites, using WHO and the United Nations Population Division databases from 1970 to 2021 or the latest available year. We predicted figures for 2024 and estimated the number of avoided cancer deaths in 1994-2024.\\n\\n\\nRESULTS\\nAll cancers combined ASR declined between 2015-2019 and 2024 across considered countries and sexes. In 2024, the lowest predicted male rate is in the Philippines (75.0/100 000) and the highest in Australia (94.2/100 000). The Republic of Korea is predicted to have the lowest female ASR (42.1/100 000) while the Philippines the highest (74.5/100 000). Over the last three decades, 121 300 deaths were estimated to be avoided in Hong Kong SAR, 69 500 in Israel, 1 246 300 in Japan, 653 300 in the Republic of Korea, 303 300 in Australia, and 89 700 among Philippine men. Mortality from stomach cancer has been decreasing since 1970 in all considered countries and both sexes. Significant decreases are at all age groups Male rates remain, however, high in Japan (8.7/100 000) and the Republic of Korea (6.2/100 000).\\n\\n\\nCONCLUSION\\nDeclining cancer mortality is predicted in the considered countries, notably reducing stomach cancer burden. Stomach cancer, however, remains a major public health issue in East Asia.\",\"PeriodicalId\":11950,\"journal\":{\"name\":\"European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/CEJ.0000000000000889\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/CEJ.0000000000000889","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

方法我们利用世界卫生组织和联合国人口司 1970 年至 2021 年或最近一年的数据库,计算了各国和各性别总癌症和 10 个最常见癌症部位的年度年龄标准化比率(ASRs)。我们预测了 2024 年的数字,并估算了 1994-2024 年间避免的癌症死亡人数。预测 2024 年男性死亡率最低的国家是菲律宾(75.0/100000),最高的国家是澳大利亚(94.2/100000)。预计大韩民国的女性 ASR 最低(42.1/100000),而菲律宾最高(74.5/100000)。在过去三十年中,香港特别行政区估计可避免 121 300 例死亡,以色列为 69 500 例,日本为 1 246 300 例,大韩民国为 653 300 例,澳大利亚为 303 300 例,菲律宾男性为 89 700 例。自 1970 年以来,所有国家的男女胃癌死亡率都在下降。所有年龄组的死亡率都有显著下降,但日本(8.7/100 000)和大韩民国(6.2/100 000)的男性死亡率仍然较高。然而,胃癌仍然是东亚的一个主要公共卫生问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Cancer mortality predictions for 2024 in selected Asian countries and Australia with focus on stomach cancer.
INTRODUCTION We estimated cancer mortality figures in five major Asian countries and Australia for 2024, focusing on stomach cancer, a leading cause of cancer-related deaths in Eastern Asia. METHODS We computed country- and sex-specific annual age-standardized rates (ASRs) for total cancers and the 10 most common cancer sites, using WHO and the United Nations Population Division databases from 1970 to 2021 or the latest available year. We predicted figures for 2024 and estimated the number of avoided cancer deaths in 1994-2024. RESULTS All cancers combined ASR declined between 2015-2019 and 2024 across considered countries and sexes. In 2024, the lowest predicted male rate is in the Philippines (75.0/100 000) and the highest in Australia (94.2/100 000). The Republic of Korea is predicted to have the lowest female ASR (42.1/100 000) while the Philippines the highest (74.5/100 000). Over the last three decades, 121 300 deaths were estimated to be avoided in Hong Kong SAR, 69 500 in Israel, 1 246 300 in Japan, 653 300 in the Republic of Korea, 303 300 in Australia, and 89 700 among Philippine men. Mortality from stomach cancer has been decreasing since 1970 in all considered countries and both sexes. Significant decreases are at all age groups Male rates remain, however, high in Japan (8.7/100 000) and the Republic of Korea (6.2/100 000). CONCLUSION Declining cancer mortality is predicted in the considered countries, notably reducing stomach cancer burden. Stomach cancer, however, remains a major public health issue in East Asia.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The PROPHET project paves the way for personalized prevention in the future healthcare. Prostate cancer burden in major BRICS countries, 1990-2019: findings from the 2019 global burden of disease study. Cancer mortality predictions for 2024 in selected Asian countries and Australia with focus on stomach cancer. Non-contrast MRI and post-mastectomy silicone breast implant rupture: preventing false positive diagnoses. Comment to: Inequalities in adherence to cervical cancer screening in Portugal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1